[Immunological aspects in experimental oncology].
D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn / Q000276:immunology*; D000941:Antigens / Q000096:biosynthesis; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002462:Cell Membrane / Q000187:drug effects; D004267:DNA Viruses / Q000276:immunology; D004279:DNA, Viral / Q000494:pharmacology; D006648:Histocompatibility; D007108:Immune Tolerance; D007112:Immunity, Maternally-Acquired; D051379:Mice / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control; D011120:Polyomavirus / Q000276:immunology* / Q000472:pathogenicity; D013934:Thymectomy / Q000009:adverse effects; D014181:Transplantation Immunology
D000941:Antigens; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D004279:DNA, Viral
Immunologische Aspekte in der experimentellen Onkologie.